anya-wagnerEducation

Free University of Berlin/ Benjamin Franklin University, M.D., 1997

Post Doctoral

Residency, Charité, Department of Medicine, 1998-2000
Postdoctoral Fellowship, Northwestern University Medical School, 2000-2001
Internal Medicine Residency, Duke University, 2004-2007
Cardiovascular Fellowship, Hahnemann University Hospital, Drexel College of Medicine, 2008-2011
Visiting Assistant Professor of Medicine, Duke University Hospital Medical Center, 2001-2004 & 2007- 2008

Certifications

Board Certified in Internal Medicine
Board Certified in Nuclear Cardiology
Board Certified in Echocardiography
Board Certified in Internal Medicine, Cardiovascular Disease

Honors & Awards

Connecticut Magazine “Top Doctors” 2016 & 2017 & 2018
Best Oral Presentation, Society of German Cardiology
Best Oral Presentation, SCMR
Research Grant from the German Research Society
Magna Cum Laude, Free University Berlin
Steering Committee Member: EuroCMR Registry
Fellow, American College of Cardiology

Position

St. Vincent’s Medical Center, Connecticut
Medical Director Cardiac Rehab, St. Vincent’s Medical Center, Connecticut
Medical Director for Women Health, St. Vincent’s Medical Center, Connecticut

Lectureships/Seminar Invitations

Norwalk Hospital, Connecticut, 2/2015, Grand Rounds: Role of CMR to Assess Cardiomyopathies
St. Vincent Hospital, Connecticut, 2/2014, Grand Rounds: Risk Assessment of Cardiomyopathies
EuroCMR, Florence, Italy, 5/2013, Chairperson: Poster Session
EuroCMR, Florence, Italy: 5/2013, Invited Lecture: How CMR Changes Clinical Practice
St. Vincent Hospital, Connecticut, 2/2013, Grand Rounds: Viability Imaging by Cardiac MRI
Stamford Hospital, Connecticut, 10/2011, Grand Rounds: Viability Imaging by Cardiac MRI
University of Miami, Florida, 3/2011, Grand Rounds: Viability Imaging by Cardiac MRI
Drexel College of Medicine, Department of Radiology, 10/2010, Grand Rounds: Viability Imaging
Robert Bosch Hospital, Stuttgart, Germany, 11/2009, Grand Rounds: Viability Imaging
Duke University, Durham, 10/2005, CMR Course, Stress Cardiac MRI
Duke University, Durham, 10/2004, CMR Course: Non-ischemic Cardiomyopathies
Robert Bosch Hospital, 11/2003, Stuttgart, Germany, CMR Course: Viability Imaging
Duke University, Durham, 10/2003, Grand Rounds: Hypertrophic Cardiomyopathy
Duke University, Durham, 10/2002, Grand Rounds: Myocarditis
Free University of Berlin, Germany, 6/2002, Grand Rounds: Viability Imaging

Peer Reviewer

Circulation Imaging, since 2012
Journal of American College of Cardiology: Cardiac Imaging since 2012
European Heart Journal, since 2010
Journal of American College of Cardiology, since 2003
Journal of Cardiovascular Magnetic Resonance, since 2003
Circulation, since 2002

Peer Reviewed Publications

Bruder O, Schneider S, Pilz G, van Rossum AC, Schwitter J, Nothnagel D, Lombardi M, Buss S, Wagner A, Petersen S, Greulich S, Jensen C, Nagel E, Sechtem U, Mahrholdt H. 2015 Update on acute adverse reactions to Gadolinium based contrast agents in Cardiovascular MR. Large Multi-national and multi- ethnical population experience with 37788 patients from the EuroCMR Registry. JACC Cardiovasc Imaging. 2015;17:58

Moschetti K, Favre D, Pinget C, Pilz G, Petersen S, Wagner A, Wasserfallen J, Schwitter J
Comparative cost-effectiveness analyses of cardiovascular magnetic resonance and coronary angiography combined with fractional flow reserve for the diagnosis of coronary artery disease
Journal of Cardiovascular Magnetic Resonance 2014;16:13.

Moschetti K, Favre D , Pinget C, Pilz G, Petersen S, Wagner A, Wasserfallen J, Schwitter J
Influence of disease prevalence on cost-effectiveness of magnetic resonance imaging versus coronary angiography combined with fractional flow reserve testing
Journal of Cardiovascular Magnetic Resonance 2014;16 :O98.

Schumm J, Greulich S, Wagner A, Grün S, Ong P, Bentz K, Klingel K, Kandolf R, Bruder O, Schneider S, Sechtem U, Mahrholdt H. Cardiovascular magnetic resonance risk stratification in patients with clinically suspected myocarditis. J Cardiovasc Magn Reson. 2014:16.

Klinke V, Muzzarelli S, Lauriers N, Locca D, Vincenti G, Monney P, Lu C, Nothnagel D, Pilz G, Lombardi M, van Rossum AC, Wagner A, Bruder O, Mahrholdt H, Schwitter J. Quality assessment of cardiovascular magnetic resonance in the setting of the European CMR registry: description and validation of standardized criteria. J Cardiovasc Magn Reson. 2013;15:55.

Greulich S, Deluigi CC, Gloekler S, Wahl A, Kramer U, Nothnagel D, Buetel H, Schumm J, Grün S, Ong P, Wagner A, Schneider S, Nassenstein K, Sechtem U, Bruder O, Mahrholdt H: Cardiovascular Magnetic Resonance Imaging predicts death and other adverse events in patients with suspected cardiac sarcoidosis. JACC Cardiovasc Imaging. 2013;6:501-11.

Bruder O, Wagner A, Lombardi M, Schwitter J, van Rossum AC, Pilz G, Nothnagel D, Steen H, Petersen SE, Nagel E, Prasad S, Schumm J, Greulich S, Cagnolo A, Monney P, Deluigi CC, Dill T, Frank H, Sabin GV, Schneider S, Mahrholdt H: European Cardiovascular Magnetic Resonance (EuroCMR) Registry – Multi National Results from 57 Centers in 15 Countries. J Cardiovasc Magn Reson. 2013; 13:9-15.

Grün S, Schumm J, Greulich S, Wagner A, Schneider S, Bruder O, Kispert E, Hill S, Ong P, Klingel K, Kandolf R, Sechtem U, Mahrholdt H. Long-term follow-up of biopsy proven viral myocarditis; predictors of mortality and incomplete recovery. J Am Coll Cardio. 2012; 59:1604-15.

Moschetti K, Muzzarelli S, Pinget C, Wagner A, Pilz G, Wasserfallen JB, Schulz-Menger J, Nothnagel D, Dill T, Frank H, Lombardi M, Bruder O, Mahrholdt H, Schwitter J. Cost evaluation of cardiac magnetic resonance imaging versus coronary angiography for the diagnostic work-up of coronary artery disease: Application of the European Cardiovascular Magnetic Resonance Registry data to the German, Swiss, and United States health care systems. J Cardiovasc Magn Reson. 2012, 14;14-35.

Rossum A, Schwitter J, Nagel E, Senges J, Sabin G, Sechtem U, Mahrholdt H. Acute adverse reactions to gadolinium-based contrast agents in CMR multicenter experience with 17,767 patients from the EuroCMR Registry. JACC Cardiovasc Imaging. 2011;4:1171-6.

Rossum A, Schwitter J, Nagel E, Senges J, Sabin G, Sechtem U, Mahrholdt H. Acute adverse reactions to gadolinium-based contrast agents in CMR multicenter experience with 17,767 patients from the EuroCMR Registry. JACC Cardiovasc Imaging. 2011;4:1171-6.

Deluigi CC, Ong P, Hill S, Wagner A, Kispert E, Klingel K, Kandolf R, Sechtem U, Mahrholdt H. ECG findings in comparison to cardiovascular MR imaging in viral myocarditis. Int J Cardiol. 2011 Aug 31.

Bruder O, W Rossum A, Schwitter J, Nagel E, Senges J, Sabin G, Sechtem U, Mahrholdt H. Acute adverse reactions to gadolinium-based contrast agents in CMR multicenter experience with 17,767 patients from the EuroCMR Registry. JACC Cardiovasc Imaging. 2011;4:1171-6.

Wagner A, Jensen CJ, Schneider S, Ong P, Kispert EM, Nassenstein K, Schlosser T, Sabin GV, Sechtem U, Mahrholdt H. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardio. 2010;56:875-87.

Wagner A, Bruder O, Mahrholdt H. Myocarditis: Update and Critical Assessment. Curr Cardiovasc Imaging Rep. 2010;3:57-64.

Bruder O, Wagner A, Mahrholdt H. Lessons learned from the European cardiovascular magnetic resonance registry. Curr Cardiovasc Imaging Rep. 2010;3:171-74.

Bruder O, Wagner A, Lombardi M, Mahrholdt H. Correspondence: Letter to the Editor. J Am Coll Cardio. 2010;412-413.

Wagner A, Bruder O, Schneider S, Dill T, Hombach V, Lombardi M, van Rossum AC, Schwitter J, Senges J, Sabin GV, Sechtem U, Mahrholdt H, Nagel E. Current variables, definitions, and endpoints of the European cardiovascular magnetic resonance registry. J Cardiovasc Magn Resn. 2009;11:11-43.

Bruder O, Schneider S, Nothnagel D, Dill T, Hombach V, Schulz-Menger J, Nagel E, Lombardi M, van Rossum AC, Wagner A, Schwitter J, Senges J, Sabin GV, Sechtem U, Mahrholdt H. EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. J Am Coll Cardio.
2009;541457-66.

Rehwald WG, Wagner A, Sievers B, Kim RJ, Judd MR. Cardiovascular MRI: its current and future use in clinical practice. Expert Rev Cardiovasc Ther. 2007;5:307-21.

Wagner A, Mahrholdt H, Thomson L, Hager S, Meinhardt, Rehwald W, Parker M, Shah D, Sechtem U, Kim RJ, Judd RM. Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on MRI delayed contrast enhancement. J Am Coll Cardiol. 2006;47:2027-2033.

Mahrholdt H, Wagner A, Deluigi CC, Hager S, Kispert EM, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Klingel K, Kandolf R, Sechtem U. Presentation, patterns of myocardial damage and clinical course of viral myocarditis. Circulation. 2006;114:1581-9

Wagner A, Mahrholdt H, Kim RJ, Judd RM. Use of CMR to assess viability. Curr Cardiol Rep. 2005;7:59-64.

Judd RM, Wagner A, Rehwald W, Albert T, Kim RJ. Technology insight: assessment of myocardial viability by delayed-enhancement magnetic resonance imaging. Nature Clinical Practice Cardiovascular Medicine. 2005;3:150-8.

Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischemic cardiomyopathies. Eur Heart J. 2005;26:1461-74.

Van den Bos EJ, Thompson RB, Wagner A, Mahrholdt H, Morimoto Y, Thomson LE, Wang LH, Judd JM, Taylor DA. Functional assessment of myoblast transplantation for cardiac repair with MRI. Eur J Heart Fail. 2005;7:435-43.

Klem I, Rehwald WG, Heitner J, Wagner A, Albert T, Parker M, Kim RJ, Judd RM. Non-invasive assessment of blood flow based on magnetic resonance global coherent free precession. Circulation. 2005;111:1033-9.

Mahrholdt H, Zhydkov A, Hager S, Mangin M, Meinhardt G, Vogelsberg H, Wagner A, Sechtem U. Left ventricular wall motion abnormalities and wall thinning can cause false positive results of routine SPECT perfusion imaging for detection of myocardial infarction. Eur Heart J. 2005;26:2127-35.

Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Vogelsberg H, Fritz P, Klingel K, Kandolf R, Sechtem U. Cardiovascular Magnetic Resonance Assessment of Human Myocarditis; A Comparison to Histology and Molecular Pathology. Circulation. 2004;109:1250-1258.

Kupfahl C, Honold M, Meinhardt G, Vogelsberg H, Wagner A, Mahrholdt H, Sechtem U. Evaluation of aortic stenosis using cardiovascular magnetic resonance imaging: a comparison to established clinical routine techniques. Heart. 2004;90:893-901.

Wagner A, Mahrholdt H, Holly T, Elliott M, Parker M, Klocke FJ, Kim RJ, Judd RM. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361:374-9.

Wagner A, Mahrholdt H, Sechtem U, Kim RJ, Judd JM. Myocardial perfusion and viability, Magn Reson Imaging Clin N Am. 2003;11:49-66.

Wagner A, Schulz-Menger J, Strohm O, Dietz R, Friedrich MG. Long-term follow-up of patients with acute myocarditis by magnetic resonance imaging. MAGMA. 2003;16:17-20.

Mahrholdt H, Wagner A, Honold M, Wedemeyer I, Sechtem U. Magnetic resonance assessment of cardiac function, infarct scar distribution, and ventricular remodeling in the setting of ischemic cardiomyopathy.
Circulation. 2003;107:103e -104.

Mahrholdt H, Wagner A, Parker M, Regenfus M, Fieno DS, Bonow RO, Kim RJ, Judd RM. Relationship of contractile function to transmural extent of infarction in patients with chronic coronary artery disease. J Am Coll Cardiol. 2003;42:505-12.

Van den Bos EJ, Wagner A, Mahrholdt H, Thompson RB, Morimoto Y, Sutton BS, Judd JM, Taylor DA. Improved efficacy of stem cell labeling for magnetic resonance imaging studies by the use of cationic liposomes. Cell Transplant. 2003;12:743-56.

Mahrholdt H, Wagner A, Holly T, Elliott M, Kim RJ, Judd RM. Reproducibility of chronic infarct size measurements by contrast enhanced MRI. Circulation. 2002;106:2322-27.

Mahrholdt H, Wagner A, Judd RM, Sechtem U. Myocardial viability by cardiac magnet resonance imaging. Eur Heart J. 2002;23:602-19.

Mahrholdt H, Wagner A, Geissler A, Sechtem U. Infarkt und Vitalitätsdiagnostik mittels kontrastverstärkter Magnetresonanztomographie. Deutsch Med Woch. 2002;127:1264-71.

Choudhury L, Mahrholdt H, Wagner A, Choi K, Elliot MD, Klocke F, Bonow RO, Judd RM, Kim RJ. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;40:2156-64.

Friedrich MG, Strohm O, Kivelitz D, Gross W, Wagner A, Schulz-Menger J, Liu X, Hamm B, Dietz R. Behavior of implantable coronary stents during magnetic resonance imaging. Internal Journal of Cardiovascular Intervention. 1999;2:217-22.

Erbes R, Wagner A, Schaberg T, Lode H, Mauch H, W. MRSA infections in patients with pulmonary diseases. Pneumologie. 1996;50:706-11.

Book Chapters

Rehwald WG, Wagner A, Albert T, Sievers B, Dyke C, Elliott M, Grizzard JD, Kim RJ, Judd R. Clinical CMR imaging techniques. Churchill Livingstone. Editors Manning WJ and Pennell D. 2nd edition. 2010.

Judd RM, Albert T, Rehwald WG, Wagner A. CMR/SAP: Introduction to Physics of Scanning. Editor Hundley G, American College of Cardiology Foundation 2004.

Mahrholdt H, Wagner A, Sechtem U. Congenital heart disease and cardiomyopathies. Editiors Nagel, van Rossum and Fleck. Springer, Berlin, Heidelberg, New York, Tokyo, 2004 (ISBN 3-7985-1402-X).

Wagner A, Mahrholdt H, Sechtem U, Kim RJ, Judd JM. Myocardial perfusion and viability, Magn Reson Imaging Clin N Am. 2003;11:49-66.

Wagner A, Mahrholdt H, Thomason L, Sechtem U, Kim RJ, Judd RM. Assessment of myocardial viability using cardiovascular MR imaging. Martin Dunitiz Publishing, London. Editors Fayad ZA and Lardo AC.
2003;8:127-154.

Mahrholdt H, Wagner A, Judd RM, Sechtem U. Stress echocardiography versus magnetic resonance imaging. Springer (Berlin, Heidelberg, New York, Tokyo). Editor E. Picano, 2003; 35, 403-418 (ISBN 3- 540-00162-X).